Found: 2
Select item for more details and to access through your institution.
Plasma cell–directed therapy for rituximab-refractory PLA2R<sup>+</sup> membranous nephropathy.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 12, p. 2851, doi. 10.1093/ndt/gfad135
- By:
- Publication type:
- Article
Complement C5 inhibition reverses bleomycin-induced thrombotic microangiopathy.
- Published in:
- Clinical Kidney Journal, 2021, v. 14, n. 4, p. 1275, doi. 10.1093/ckj/sfaa101
- By:
- Publication type:
- Article